Bafna Pharmaceuticals Reports Q1 2026 Unaudited Results; Announces 31st AGM Details
Bafna Pharmaceuticals Limited has announced the unaudited financial results for the first quarter ended June 30, 2026. The Company also provided updates regarding its upcoming Annual General Meeting (AGM) and management's position on ongoing GST matters.The Board of Directors held a meeting on August 11, 2026, which included considering and approving the unaudited financial results along with a Limited Review Report issued by the Statutory Auditors for the first quarter ended June 30, 2026.
Financial Performance Highlights
Bafna Pharmaceuticals reported strong revenue performance in the first quarter of fiscal year 2027. Total income stood at 2,849.42 units for the quarter.The unaudited results for Q1 ended June 30, 2026, are summarized below:
| Particulars | Quarter Ended 30th June 2026 (Unaudited) |
|---|---|
| Revenue from Operations | 2,658.32 |
| Other Income | 191.10 |
| Total Income | 2,849.42 |
| Total Expenses | 2,841.91 |
| Profit for the Period (Before Tax) | 7.51 |
| Total Comprehensive Income for the period | 13.59 |
The Company’s Earnings Per Share (EPS) for the quarter stood at Basic EPS of 0.03 and Diluted EPS of 0.03.
Corporate Meeting and AGM Details
In addition to the financial results, Bafna Pharmaceuticals provided key dates concerning its corporate governance:- AGM Date: The 31st Annual General Meeting (AGM) is scheduled for Friday, September 11, 2026.
- Meeting Format: The AGM will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
- Book Closure: The Register of Members and Share Transfer Books will remain closed from Saturday, September 05, 2026, to Friday, September 11, 2026.
- Cut-Off Date: The cut off date for determining member eligibility for voting at the 31st AGM is set as Friday, September 04, 2026.
GST Matters and Auditor's Review
The independent audit review highlighted matters related to GST demands and recoveries that are currently under dispute. The management noted receiving a demand order from GST authorities raising a liability amounting to INR 235.47 Lakhs. Furthermore, an order was received from the Joint Commissioner concerning the recovery of GST refunds availed in earlier years, totaling INR 331.09 Lakhs, along with applicable interest and penalty.The Company has preferred an appeal against the GST demand and has obtained a stay for the refund amount before the Madras High Court through a writ petition. Management expressed confidence in prevailing against the positions adopted by the GST authorities and did not anticipate any adverse financial outcome concerning these matters.
BAFNAPH Stock Price Movement
Today, the stock shed nearly 2.0% in post-market trading, ultimately settling at ₹273.75 after dipping from its previous close of ₹279.30. The shares traded a modest volume of 6,583 during today's session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.